Literature DB >> 526329

The metabolism of 2'-deoxycoformycin by L1210 cells in vitro.

P M Venner, R I Glazer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526329     DOI： 10.1016/0006-2952(79)90070-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

Authors:  M B Faletto; W H Miller; E P Garvey; M H St Clair; S M Daluge; S S Good
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 3.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  J F Smyth; R M Paine; A L Jackman; K R Harrap; M M Chassin; R H Adamson; D G Johns
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

Authors:  A S Bagnara; M S Hershfield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.